What is the ticker symbol for enGene?

enGene trades under the ticker ENGN on NASDAQ.

What sector does enGene operate in?

enGene is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ENGN in a portfolio?

PortView shows ENGN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

enGene (ENGN) Stock Analysis

NASDAQHealthcareBiotechnology

$1.56+0.32%

1-year price historyRange $1.44 – $12.17

52-week range$1.56

$1.40$12.25

Track ENGN in your portfolio for free · Portfolio tracker

What enGene does

Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm. Its core mission involves pioneering genetic pharmaceuticals, achieved by administering therapeutic agents directly to mucosal tissues and other bodily organs. A key asset in its pipeline is EG-70, also known as detalimogene voraplasmid. This innovative non-viral immunotherapy is being developed to treat non-muscle invasive bladder cancer in patients diagnosed with carcinoma-in-situ (Cis) who have shown no improvement after Bacillus Calmette-Guérin therapy. The company was established in 2023 and is headquartered in Saint-Laurent, Canada.

Key metrics

Market cap

$104.21M

P/E (TTM)

-0.75

EPS (TTM)

$-2.07

Beta

-0.28

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.81

200-day avg

$4.47

52-week high

$12.25

52-week low

$1.40

CEO

Ronald H. W. Cooper

ETFs linked to ENGN

Broad-market and Healthcare sector ETFs an investor holding enGene is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ENGN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ENGN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for enGene?: enGene trades under the ticker ENGN on NASDAQ.
Which exchange is ENGN listed on?: ENGN is listed on NASDAQ.
What sector does enGene operate in?: enGene is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ENGN in a portfolio?: PortView shows ENGN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.